复合药房市场概况、增长、趋势、分析、研究报告(2020-2028 年)

  • Report Code : TIPRE00005407
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 149
Buy Now

Compounding Pharmacies Market Trends and Size - 2028

Buy Now

 

[研究报告] 2020 年复合药房市场价值为 94.428 亿美元,预计到 2028 年将达到 149.951 亿美元;预计 2021 年至 2028 年的复合年增长率为 6.1%。

 

 

市场洞察和分析师观点:

配药药房或复合药房的作用是根据患者的需求混合成分并制造市场上买不到的药物。药房配药自古以来就存在。在剂量强度和剂型有限、对某些成分的药物过敏、儿科、化疗和兽医等情况下,配药是必不可少的。此外,配制药物增强了药剂师对制定和实施患者治疗计划的贡献,并提供高品质的定制药物。市场受到全球药品短缺危机、配制药物相关好处以及定制药物(个性化药物)日益普及等因素的驱动。然而,产品召回和严格的监管要求可能会在预测期内阻碍配药药房市场的增长。

 

 

增长动力和挑战:

配药药房或专科药房为患者提供医生推荐的、市场上买不到的药物。由于配药药房具有多种相关优势,因此其需求正在增长。例如,配药药房强烈推荐给过敏患者或需要少量特定药物的年轻人。此外,如果患者乳糖不耐症、葡萄糖不耐症或对商业药物不必要的染料过敏,药剂师可以改变成分。此外,药剂师可以根据儿童的需要减少剂量,为儿童添加口味,将成人剂量加倍。对于口服药物敏感的患者,可以将药丸配方改为液体,以方便服用。配药药剂师可以为仍依赖这些药物的患者提供已停产的药物。他们可以重新制作药物成分以保护患者的健康。

目前,配药药剂师可以获得最优质的成分、最新的研究、技术和质量控制规则,以满足患者的需求。此外,当患者吞咽药丸困难时,配药药房可以创造替代剂型。根据患者和药物类型,配药药房可以使服药变得不那么困难。例如,某些药物可以重新配制成外用溶液,涂抹在皮肤上并被血液吸收。这些好处导致对配药药房的需求增加。

此外,预计在预测期内,Fagron, Inc.、Elixir Compounding Pharmacy、Avella speciality pharmacy、B. Braun Melsungen AG、PharMEDium Healthcare Holdings, Inc.、Fresenius Kabi AG、Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd、Triangle Compounding Pharmacy、Vertisis Custom Pharmacy 和 US Compounding Inc. 等市场主要参与者将为全球复合药房市场带来巨大的增长机会。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

复合药房市场:

复合药房市场
  • Compounding Pharmacies Market
    复合年增长率(2020 - 2028 年)
    6.1%
  • 2020 年市场规模
    94.4 亿美元
  • 2028 年市场规模
    150 亿美元

市场动态

增长动力
  • 全球药品短缺危机
  • 复合药物的好处
未来的趋势
  • 不断增加的产品制造和销售外包设施
机会
  • COVID-19 期间配药需求不断增长

关键人物;主力;重要一员

  •  
  • Fagron 公司
  • 药剂配制药房
  • Avella 专业药房
  • B. Braun Melsungen AG
  • PharMEDium Healthcare Holdings, Inc.
  • 费森尤斯卡比公司
  • Belle Santé 诊断与治疗研究所私人有限公司
  • 三角复合药房
  • Vertisis 定制药房

区域概况

Compounding Pharmacies Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Compounding Pharmacies Market产品
  • 口服药物
  • 外用药物
  • 栓剂
  • 其他的
Compounding Pharmacies Market治疗领域
  • 止痛药
  • 激素替代疗法
  • 皮肤病学应用
  • 其他的
Compounding Pharmacies Market地理
  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲和中美洲
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

报告细分和范围:

“全球复合药房市场”根据产品、治疗领域和地域进行细分。根据产品细分为口服药物、外用药物、栓剂和其他。根据治疗领域,复合药房市场细分为止痛药、激素替代疗法、皮肤病应用和其他。根据地域,复合药房市场细分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)

 

节段分析:

根据产品,分为口服药物、外用药物、栓剂和其他。2020 年,口服药物占据了更大的市场份额。然而,预计外用药物部分将在预测期内实现最高的市场复合年增长率。口服是一种给药途径,通过口腔服用。它们有不同的形式,如固体片剂、胶囊、咀嚼片或锭剂,可以整个吞咽或吮吸,也可以作为可饮用的液体,如糖浆、滴剂或溶液。有时药物会被口腔内壁吸收,就像锭剂一样。在大多数情况下,口服药物成分直到进入胃或肠道才会进入血液。例如,一些活性成分,如泻药或造影剂,​​根本不会大量渗入血液。除了这些好处之外,还有一些限制因素,例如约 9% 的儿童无法吞咽小口服药片,因为他们面临一些常见的有效吞咽障碍,例如发育阶段、恐惧、焦虑和对不愉快味道的不耐受。同时,6-11 岁的儿童可以在药剂师或执业医师的指导下吞咽小口服药片。

根据治疗领域,复合药房市场细分为止痛药、激素替代疗法、皮肤病应用等。2020 年,止痛药领域占据了最大的市场份额。此外,预计未来几年,同一领域也将以最快的复合年增长率增长。疼痛是患者寻求医疗帮助的最明显症状。急性疼痛很容易发展为慢性疼痛,后来变得难以治疗。商业上方便的止痛药可以治疗慢性疾病,如关节炎、纤维肌痛、偏头痛和其他神经和肌肉疼痛;然而,这些药物可能会产生不良副作用,如头晕、嗜睡或胃部刺激。因此,许多患者通过药房配制寻求更合适的解决方案。配制是为患者开发定制药物的艺术和科学。药房配制为患者提供定制的止痛药选择。它为那些疼痛管理已成为一种生活方式的人提供了相关优势。止痛药的剂型可能包括外用乳膏、外用软膏、外用凝胶、栓剂、直肠栓剂、阴道栓剂、含片、口服溶液等。因此,疼痛管理对复合药房市场做出了贡献,预计在预测期内仍将保持这一趋势。

 

区域分析:

根据地理位置,复合药房市场分为五个主要区域:北美、欧洲、亚太地区、南美和中美以及中东和非洲。北美复合药房市场分析基于三个主要国家——美国、加拿大和墨西哥。据估计,美国复合药房市场在预测期内将占据最大的复合药房市场份额。美国复合药房市场的增长归因于市场参与者采用有机和无机战略来开发市场。例如,2021 年 1 月,Nephron Pharmaceuticals Corporation 在非常成功的 Nephron 503B 外包设施运营下推出了一款全新的注射器。环烯烃共聚物注射器 (COC) 具有玻璃般的外观,但抗破碎且重量轻。COC 注射器适用于多种药物,包括高粘度药物,并可延长产品保质期。由于上述因素,预计该国在预测期内将出现快速增长。

英国是全球复合药房市场的第二大地区。由于复合药物有效性的提高等因素,预测期内德国在欧洲复合药房市场中占有最大份额,这些因素可能是推动该地区复合药房市场增长的重要因素。英国正在引领现代医疗保健行业的发展。老年人口的增加是推动英国复合药房行业增长的主要因素。由于生育率从高到低的变化以及主要死亡原因从传染病和细菌性疾病转向慢性病和非传染性疾病,人口寿命有所提高。此外,复合药房的低成本将在未来几年有利于市场增长。接近高龄的人口比例增加,以及看起来更年轻的需求日益增长,将推动对抗衰老产品的需求,例如女性生物同质激素替代疗法、人类生长激素和主要在复合药房生产的高质量皮肤病产品。

此外,复合药物提供的便利性和优势将是影响业务发展的另一个因素。需要目前市场上无法获得的强度治疗和目前尚未广泛获得的药物的个人可以通过高度先进的复合药房获得。复合药房扩大难以找到的药物(如激素疗法)供应的潜力将有助于需求增长。由于该国上述因素,预计英国复合药房市场将在预测期内实现增长。

 

行业发展和未来机遇:

以下列出了全球复合药房市场的主要参与者采取的各种举措:

  • B. Braun Melsungen AG 和 Grifols 建立战略合作伙伴关系,以提高医院配药产量和服务。Grifols 是血浆衍生药物的领先生产商,在美国设有配药中心
  • Triangle Compounding Pharmacy 推出了复合洗手液,以对抗 COVID-19 疫情。Triangle Compounding Pharmacy 是美国第一家提供药用级洗手液的公司

 

复合药房市场报告范围

报告属性细节
2020 年市场规模94.4 亿美元
2028 年市场规模150亿美元
全球复合年增长率(2020 - 2028)6.1%
历史数据2018-2019
预测期2021-2028
涵盖的领域按产品
  • 口服药物
  • 外用药物
  • 栓剂
  • 其他的
按治疗领域
  • 止痛药
  • 激素替代疗法
  • 皮肤病学应用
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • Fagron 公司
  • 药剂配制药房
  • Avella 专业药房
  • B. Braun Melsungen AG
  • PharMEDium Healthcare Holdings, Inc.
  • 费森尤斯卡比公司
  • Belle Santé 诊断与治疗研究所私人有限公司
  • 三角复合药房
  • Vertisis 定制药房
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

竞争格局和重点公司:

配药药房市场的一些知名参与者包括 Fagron, Inc.、Elixir Compounding Pharmacy、Avella speciality pharmacy、B. Braun Melsungen AG、PharMEDium Healthcare Holdings, Inc.、Fresenius Kabi AG、Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd、Triangle Compounding Pharmacy、Vertisis Custom Pharmacy 和 US Compounding Inc. 等,它们是配药药房市场的领先公司。这些公司专注于各种增长战略,如合作、产品发布、业务扩展、协议等,以保持其在全球市场的地位。它们在全球拥有广泛的业务,这使它们能够服务于大量客户,从而增加了其配药药房的市场份额。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the compounding pharmacies market across the globe?

The factors that are driving growth of the market are drug shortage crisis across the globe, benefits associated with compounded medications and increasing adoption of customized medicine (Personalized medicine).

Who are the major players in the compounding pharmacies market?

The compounding pharmacies market majorly consists of the players such as Fagron, Inc., Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy and US Compounding Inc.

What is Compounding Pharmacies?

Compounding pharmacies or compound pharmacy role is to mix ingredients as per patients' needs and manufacture drugs that are not commercially available. Pharmacy compounding has been present since the beginning of time. It is essential in cases such as limited dosage strengths and dosage forms, drug allergies to certain ingredients, pediatrics, chemotherapy and veterinary medicine. Further, compounded medicines enhance pharmacist contribution to developing and implementing patient therapeutic plans and provide customized medications of high pharmaceutical quality. Additionally, as per law, compounding drugs does not include making copies of commercially available drug products. Compounding pharmacists can make flavored drugs in different dosage forms, such as liquids, topical creams, suppositories, transdermal gels, or other dosage forms suitable for patient's unique needs.

The List of Companies - Compounding Pharmacies Market

  1. Fagron, Inc.           
  2. Elixir Compounding Pharmacy        
  3. Avella specialty pharmacy  
  4. B. Braun Melsungen AG      
  5. PharMEDium Healthcare Holdings, Inc.        
  6. Fresenius Kabi AG
  7. Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd         
  8. Triangle Compounding Pharmacy    
  9. Vertisis Custom Pharmacy  
  10. US Compounding Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..